Search
for
Sort by
Research 30 of 1000+
- Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report
- Prophylaxis and Management of Skin Toxicities
- Cutaneous toxicities of cancer therapy
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Dermatological adverse events with taxane chemotherapy
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Effect of a medicinal and edible decoction YH0618 on chemotherapy-induced dermatologic toxicity: a randomized controlled trial
- Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Risks of Skin, Hair, and Nail Supplements
- Skin toxicity of anti‐cancer therapy
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Adverse effects of voriconazole: Over a decade of use
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Toxicity of repeated oral intake of organic selenium, inorganic selenium, and selenium nanoparticles: A review
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- “PRIDE” Complex
- Therapeutic Efficacy of Combination Therapy Using Oral Cyclosporine with a Dietary Supplement (Pantogar®) in Twenty-Nail Dystrophy
- Management of Toxicities of Targeted Therapies
- Management of Dermatologic Toxicities
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus